Published on The Nathan Kline Institute for Psychiatric Research (https://www.nki.rfmh.org)

Home > Transcranial photobiomodulation for mild cognitive impairment/Alzheimer's Disease (TRAP-AD)

Transcranial photobiomodulation for mild cognitive impairment/Alzheimer's Disease (TRAP-AD) [1]

Are you experiencing memory problems? If you are 65+, you may qualify to participate in our study investigating an experimental treatment device for memory problems using near-infrared light therapy at the Nathan Kline Institute! Compensation will be provided for time and transportation.

Study Length: 
4-6 months
Disorder/Condition: 
Alzheimer’s Disease / Mild Cognitive Impairment
Inclusion Criteria: 
  • Have memory problems
  • Willing to travel to NKI
Study Title (brief): 
Transcranial photobiomodulation for mild cognitive impairment/Alzheimer's Disease (TRAP-AD)
Study Description (brief): 

Are you experiencing memory problems? If you are 65+, you may qualify to participate in our study investigating an experimental treatment device for memory problems using near-infrared light therapy at the Nathan Kline Institute! Compensation will be provided for time and transportation.

Study Contact: 

Zamfira Parincu, 845-398-6571 or zamfira.parincu@nki.rfmh.org [2]

Study Location: 
Nathan Kline Institute (NKI)
Source URL:https://www.nki.rfmh.org/content/transcranial-photobiomodulation-mild-cognitive-impairmentalzheimers-disease-trap-ad

Links
[1] https://www.nki.rfmh.org/content/transcranial-photobiomodulation-mild-cognitive-impairmentalzheimers-disease-trap-ad [2] mailto:zamfira.parincu@nki.rfmh.org